Usefulness of Ocimum sanctum Linn. in Cancer Prevention: An Update

  • Naveen Kaushal
  • Suresh Rao
  • Preety Ghanghas
  • Soniya Abraham
  • Thomas George
  • Sueallen D’souza
  • Jeffey M. Mathew
  • Jessica Chavali
  • Mallappa Kumara Swamy
  • Manjeshwar Shrinath Baliga


The information on the use of herbs in various traditional medical practices has greatly contributed toward the discovery of effective lead molecules against diseases. During the last few decades, many plants have been studied for their various pharmacological properties, and wide ranging research evidences suggest their immense therapeutic potential. Since time immemorial, the plant Ocimum sanctum Linn., generally referred to as tulsi or holy basil, has been widely used in different systems of folk medicines of India for treating various diseases and ailments. Tulsi consists of several bioactive phytocompounds, such as flavonoids, saponins, triterpenoids, tannins, and phenolics. Scientific investigations have revealed a diverse range of pharmacological properties including antimicrobial, antioxidant, antiamoebic, antidiarrheal, antiplasmodial, anti-inflammatory, immunomodulatory, hepatoprotective, antiasthmatic, analgesic, antiulcer, wound healing anticancer, and cancer-chemopreventive activities. In this chapter, an attempt is made to summarize the diverse beneficial activities and avenues of tulsi for future research in cancer.


Anticancer agents Cancer Chemoprevention Pharmacological properties Tulsi 


  1. Aggarwal A, Mali RR (2015) Ocimum tenuiflorum- A medicinal plants with its versatile uses. Int J Rec Adv Sci Tech 2:1–10Google Scholar
  2. Aggarwal BB, Prasad S, Reuter S, Kannappan R, Yadev VR, Park B, Kim JH, Gupta SC, Phromnoi K, Sundaram C, Prasad S, Chaturvedi MM, Sung B (2011) Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: reverse pharmacology and bedside to bench approach. Curr Drug Targets 12:1595–1553CrossRefPubMedPubMedCentralGoogle Scholar
  3. Anandjiwala S, Kalola J, Rajani M (2006) Quantification of eugenol, luteolin, ursolic acid, and oleanolic acid in black (Krishna Tulasi) and green (Sri Tulasi) varieties of Ocimum sanctum Linn. using high-performance thin layer chromatography. J AOAC Int 89:1467–1474PubMedGoogle Scholar
  4. Anbarasu K, Vijayalakshmi G (2007) Improved shelf life of protein-rich tofu using Ocimum sanctum (tulsi) extracts to benefit Indian rural population. J Food Sci 72:M300–M305CrossRefPubMedGoogle Scholar
  5. Anusuya C, Manoharan S (2011) Antitumor initiating potential of rosmarinic acid in 7,12-dimethylbenz(a) anthracene- induced hamster buccal pouch carcinogenesis. J Environ Pathol 30:199–211Google Scholar
  6. Aruna K, Sivaramakrishnan VM (1992) Anticarcinogenic effects of some Indian plant products. Food Chem Toxicol 30:953–956CrossRefPubMedGoogle Scholar
  7. Ashfaq UA, Idrees S (2014) Medicinal plants against hepatitis C virus. World J Gastroenterol 20:2941–2947CrossRefPubMedPubMedCentralGoogle Scholar
  8. Attoub S, Hassan AH, Vanhoecke B, Iratni R, Takahashi T, Gaben AM, Bracke M, Awad S, John A, Kamalboor HA, Al Sultan MA, Arafat K, Gespach C, Petroianu G (2011) Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol 651:18–25CrossRefPubMedGoogle Scholar
  9. Babu LH, Perumal S, Balasubramanian MP (2012) Myrtenal, a natural monoterpene, down-regulates TNF-α expression and suppresses carcinogen induced hepatocellular carcinoma in rats. Mol Cell Biochem 369:183–193CrossRefPubMedGoogle Scholar
  10. Baliga MS, Jimmy R, Thilakchand KR, Sunitha V, Bhat NR, Saldanha E, Rao S, Rao P, Arora R, Palatty PL (2013) Ocimum sanctum L (Holy Basil or Tulsi) and its phytochemicals in the prevention and treatment of cancer. Nutr Cancer 65:26–35CrossRefPubMedGoogle Scholar
  11. Baliga MS, Rao S, Rai MP, D’souza P (2016) Radio protective effects of the Ayurvedic medicinal plant Ocimum sanctum Linn. (Holy Basil): a memoir. J Cancer Res Ther 12:20–27CrossRefPubMedGoogle Scholar
  12. Banerjee S, Prashar R, Kumar A, Rao AR (1996) Modulatory influence of alcoholic extract of Ocimum leaves on carcinogen-metabolizing enzyme activities and reduced glutathione levels in mouse. Nutr Cancer 25:205–217CrossRefPubMedGoogle Scholar
  13. Bhattacharyya P, Bishayee A (2013) Ocimum sanctum Linn. (Tulsi): an ethnomedicinal plant for the prevention and treatment of cancer. Anti-Cancer Drugs 24:659–666CrossRefPubMedGoogle Scholar
  14. Bhide SV, Zariwala MB, Amonkar AJ, Azuine MA (1991) Chemopreventive efficacy of a betel leaf extract against benzo[a]pyrene-induced forestomach tumors in mice. J Ethnopharmacol 34:207–213CrossRefPubMedGoogle Scholar
  15. Buckman SY, Gresham A, Hale P, Hruza G, Anast J, Masferrer J, Pentland AP (1998) COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19:723–729CrossRefPubMedGoogle Scholar
  16. Cai J, Zhao XL, Liu AW, Nian H, Zhang SH (2011) Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine 18:366–373CrossRefPubMedGoogle Scholar
  17. Chattopadhyay RR, Sarkar SK, Ganguly S, Medda C, Basu TK (1992) Hepatoprotective activity of O. sanctum leaf extract against paracetamol induced hepatic damage in rats. Indian J Pharmacol 3:13–18Google Scholar
  18. Chen D, Landis-Piwowar KR, Chen MS, Dou QP (2007) Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts. Breast Cancer Res 9:R80CrossRefPubMedPubMedCentralGoogle Scholar
  19. Choi SI, Jeong CS, Cho SY, Lee YS (2007) Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch Pharm Res 30:1328–1335CrossRefPubMedGoogle Scholar
  20. Croce CM (2008) Oncogenes and cancer. New Eng J Med 358:502–511CrossRefPubMedGoogle Scholar
  21. Das SK, Kumar S, Vasudevan DM (2006) Tulsi: the Indian holy power plant. Nat Prod Radiance 5:279–283Google Scholar
  22. Eswar P, Devaraj CG, Agarwal P (2016) Anti-microbial activity of Tulsi {Ocimum Sanctum (Linn)} extract on a periodontal pathogen in human dental plaque: an in vitro study. J Clin Diagn Res 10:ZC53–ZC56PubMedPubMedCentralGoogle Scholar
  23. Eyo LE, Uzoibiam BO, Ogbanya KC (2014) Comparative evaluation of wound healing effects of Ocimum gratissimum, Vernonia amygdalina and Zingiber officinale extracts on incision wound model in rats. Pharmacol Online 3:44–50Google Scholar
  24. Gayathri R, Priya DK, Gunassekaran GR, Sakthisekaran D (2009) Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats. Asian Pac J Cancer Prev 10:933–938PubMedGoogle Scholar
  25. Godhwani S, Godhwani JL, Vyas DS (1987) Ocimum sanctum: an experimental study is evaluating its anti-inflammatory, analgesic and antipyretic activity in animals. J Ethnopharmacol 21:153–163CrossRefPubMedGoogle Scholar
  26. Goel RK, Sairam K, Dorababu M, Prabha T, Rao CV (2005) Effect of standardized extract of Ocimum sanctum Linn. On gastric mucosal offensive and defensive factors. Indian J Exp Biol 43:715–721PubMedGoogle Scholar
  27. Guarino M, Rubino B, Ballabio G (2007) The role of epithelial-mesenchymal transition in cancer pathology. Pathology 39:305–318CrossRefPubMedGoogle Scholar
  28. Gupta SK, Prakash J, Srivastava S (2002) Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant. Indian J Exp Biol 40:765–773PubMedGoogle Scholar
  29. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMedPubMedCentralGoogle Scholar
  30. Karthikeyan K, Ravichandran P, Govindasamy S (1999) Chemopreventive effect of Ocimum sanctum on DMBA-induced hamster buccal pouch carcinogenesis. Oral Oncol 35:112–119CrossRefPubMedGoogle Scholar
  31. Kelm MA, Nair MG, Strasburg GM, DeWitt DL (2000) Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7–13CrossRefPubMedGoogle Scholar
  32. Kim MJ, Woo JS, Kwon CH, Kim JH, Kim YK, Kim KH (2012) Luteolin induces apoptotic cell death through AIF nuclear translocation mediated by activation of ERK and p38 in human breast cancer cell lines. Cell Biol Int 36:339–344CrossRefPubMedGoogle Scholar
  33. Lahon K, Das S (2011) Hepatoprotective activity of Ocimum sanctum alcoholic leaf extract against paracetamol-induced liver damage in Albino rats. Pharmacogn Res 3:13–18CrossRefGoogle Scholar
  34. Lee HZ, Yang WH, Bao BY, Lo PL (2010) Proteomic analysis reveals ATPdependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis. Eur J Pharmacol 642:19–27CrossRefPubMedGoogle Scholar
  35. Lin CC, Huang CY, Mong MC, Chan CY, Yin MC (2011) Antiangiogenic potential of three triterpenic acids in human liver cancer cells. J Agric Food Chem 59:755–762CrossRefPubMedGoogle Scholar
  36. Lingaiah HB, Natarajan N, Thamaraiselvan R, Srinivasan P, Periyasamy BM (2012) Myrtenal ameliorates diethylnitrosamine-induced hepatocarcinogenesis through the activation of tumor suppressor protein p53 and regulation of lysosomal and mitochondrial enzymes. Fundam Clin Pharmacol 27:443–454CrossRefPubMedGoogle Scholar
  37. Liu RH (2004) Potential synergy of phytochemicals in cancer prevention, mechanism of action. J Nutr 134:3479–3485CrossRefGoogle Scholar
  38. Mafuvadze B, Benakanakere I, Lopez Perez FR, Besch-Williford C, Ellersieck MR, Hyder SM (2011) Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Cancer Prev Res 4:1316–1324CrossRefGoogle Scholar
  39. Mafuvadze B, Liang Y, Besch-Williford C, Zhang X, Hyder SM (2012) Apigenin induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent bt-474 xenograft tumors. Horm Cancer 3:160–171CrossRefPubMedGoogle Scholar
  40. Magesh V, Lee JC, Ahn KS, Lee HJ, Lee EO, Shim BS, Jung HJ, Kim JS, Kim DK, Choi SH (2009) Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Phytother Res 23:1385–1391CrossRefPubMedGoogle Scholar
  41. Mahaprabhu R, Bhandarkar AG, Jangir BL, Rahangadale SP, Kurkure NV (2011) Ameliorative effect of Ocimum sanctum on meloxicam induced toxicity in wistar rats. Toxicology 18:130–136Google Scholar
  42. Manikandan P, Murugan RS, Abbas H, Abraham SK, Nagini S (2007a) Ocimum sanctum Linn. (Holy Basil) ethanolic leaf extract protects against 7,12-dimethylbenz(a) anthracene-induced genotoxicity, oxidative stress, and imbalance in xenobiotic-metabolizing enzymes. J Med Food 10:495–402CrossRefPubMedGoogle Scholar
  43. Manikandan P, Vidjaya Letchoumy P, Prathiba D, Nagini S (2007b) Proliferation, angiogenesis and apoptosis-associated proteins are molecular targets for chemoprevention of MNNG-induced gastric carcinogenesis by ethanolic Ocimum sanctum leaf extract. Singap Med J 48:645–651Google Scholar
  44. Manikandan P, Murugan RS, Priyadarsini RV, Vinothini G, Nagini S (2010) Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG. Life Sci 86:936–941CrossRefPubMedGoogle Scholar
  45. Manikandan P, Vinothini G, Vidya Priyadarsini RV, Prathiba D, Nagini S (2011) Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG. Investig New Drugs 29:110–117CrossRefGoogle Scholar
  46. Manoharan S, Vasanthaselvan M, Silvan S, Baskaran N, Singh AK, Kumar VV (2010) Carnosic acid: a potent chemopreventive agent against oral carcinogenesis. Chem Biol Interact 188:616–622CrossRefPubMedGoogle Scholar
  47. Markaverich BM, Shoulars K, Rodriguez MA (2011) Luteolin regulation of estrogen signaling and cell cycle pathway genes in MCF-7 human breast cancer cells. Int J Biomed Sci 7:101–111PubMedPubMedCentralGoogle Scholar
  48. Martins E (2014) The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 4:177.
  49. Nana-Sinkam SP, Powell CA (2013) Molecular biology of lung cancer, diagnosis and management of lung cancer: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e30S–e39S. CrossRefPubMedPubMedCentralGoogle Scholar
  50. Nangia-Makker P, Tait L, Hogan V, Raz A (2004) Inhibition of angiogenesis by a common herb: Ocimum sactum. Proc Am Assoc Cancer Res 64:22–27Google Scholar
  51. Ovadje P, Roma A, Steckle M, Nicoletti L, Arnason JT, Pandey S (2015) Advances in the research and development of natural health products as main stream cancer therapeutics. Evidence-Based Compl Altern Med 2015:751348Google Scholar
  52. Ozkan G, Kamiloglu S, Ozdal T, Boyacioglu D, Capanoglu E (2016) Potential use of Turkish medicinal plants in the treatment of various diseases. Molecules 21:257. CrossRefPubMedGoogle Scholar
  53. Pandey G, Madhuri S (2010) Pharmacological activities of Ocimum sanctum (Tulsi): a review. Int J Pharm Sci Rev Res 5:61–66Google Scholar
  54. Pattanayak P, Behera P, Das D, Panda SK (2010) Ocimum sanctum Linn. A reservoir plant for therapeutic applications: an overview. Pharmacogn Rev 4:95–105CrossRefPubMedPubMedCentralGoogle Scholar
  55. Perlikos F, Harrington KJ, Syrigos KN (2013) Key molecules mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol 87:1–11CrossRefPubMedGoogle Scholar
  56. Prakash P, Gupta N (2005) Therapeutic uses of Ocimum sanctum Linn. (Tulsi) with a note on eugenol and its pharmacological actions: a short review. Indian J Physiol Pharmacol 49:125–131PubMedGoogle Scholar
  57. Prashar R, Kumar A, Hewer A, Cole KJ, Davis W, Phillips DH (1998) Inhibition by and extract of Ocimum sanctum of DNA-binding activity of 7, 12-dimethylbenz[a]anthracene in rat hepatocytes in vitro. Cancer Lett 19:155–160CrossRefGoogle Scholar
  58. Sarkar A, Bhattacharjee S, Mandal DP (2015) Induction of apoptosis by eugenol and capsaicin in human gastric cancer AGS-cell-elucidating the role of p53. Asian Pac J Cancer Prev 16:6753–6759CrossRefPubMedGoogle Scholar
  59. Seethalakshmi B, Narasappa AP, Kenchaveerappa S (1982) Protective effect of Ocimum sanctum in experimental liver injury in albino rats. Indian J Pharmacol 14:63–68Google Scholar
  60. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB (2003) Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaB alpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 63:4375–4383PubMedGoogle Scholar
  61. Shivpuje P, Ammanangi R, Bhat K, Katti S (2015) Effect of Ocimum sanctum on oral cancer cell line: an in vitro study. J Contemp Dent Pract 16:709–714CrossRefPubMedGoogle Scholar
  62. Shukla S, Gupta S (2010) Apigenin: a promising molecule for cancer prevention. Pharm Res 27:962–978CrossRefPubMedPubMedCentralGoogle Scholar
  63. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRefPubMedPubMedCentralGoogle Scholar
  64. Singh S, Majumdar DK, Yadav MR (1996) Chemical and pharmacological studies on fixed oil of Ocimum sanctum. Indian J Exp Boil 34:1212–1215Google Scholar
  65. Singh S, Taneja M, Majumdar DK (2007) Biological activities of Ocimum sanctum L. fixed oil: an overview. Indian J Exp Biol 45:403–412PubMedGoogle Scholar
  66. Singh E, Sharma S, Dwivedi J, Sharma S (2012) Diversified potentials of Ocimum sanctum Linn (Tulsi): an exhaustive survey. J Nat Prod Plant Resour 2:39–48Google Scholar
  67. Sridevi M, Bright J, Yamini K (2016) Anticancer effect of Ocimum sanctum ethanolic extract in non-small cell lung carcinoma cell line. Int J Pharm Pharm Sci 8:8–20Google Scholar
  68. Srinivas N, Sali K, Bajoria AA (2016) Therapeutic aspects of Tulsi unraveled: a review. J Indian Acad Oral Med Radiol 28:17–23CrossRefGoogle Scholar
  69. Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY, Xi T (2009) Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anti-Cancer Drugs 20:249–258CrossRefPubMedGoogle Scholar
  70. Tong X, Pelling J (2013) Targeting the PI3K/Akt/mTOR axis by apigenin for cancer prevention. Anti Cancer Agents Med Chem 13:971–978CrossRefGoogle Scholar
  71. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global Cancer statistics, 2012. CA Cancer J Clin 65:87–108CrossRefPubMedPubMedCentralGoogle Scholar
  72. Tsao AS, Kim ES, Hong WK (2004) Chemoprevention of cancer. CA Cancer J Clin 54:150–180CrossRefPubMedGoogle Scholar
  73. Ubaid RS, Anantrao KM, Jaju JB, Mateenuddin M (2003) Effect of Ocimum sanctum leaf extract on hepatotoxicity induced by antitubercular drugs in rats. Indian J Physiol Pharmacol 47:465–470PubMedGoogle Scholar
  74. Udupa SL, Shetty S, Udupa AL, Somayaji SN (2006) Effect of Ocimum sanctum Linn. on normal and dexamethasone suppressed wound healing. Indian J Exp Biol 44:49–54PubMedGoogle Scholar
  75. Vats V, Grover JK, Rathi SS (2002) Evaluation of antihyperglycemic and hypoglycemic effect of T. foenumgraecum, O. sanctum and P. marsupium in normal and alloxanized diabetic rats. J Ethnopharmacol 79:95–100CrossRefPubMedGoogle Scholar
  76. Verschooten L, Smaers K, Van Kelst S, Proby C, Maes D, Declercq L, Agostinis P, Garmyn M (2010) The flavonoid luteolin increases the resistance of normal, but not malignant keratinocytes, against UVB-induced apoptosis. J Invest Dermatol 130:2277–2285CrossRefPubMedGoogle Scholar
  77. Vidhya N, Devaraj SN (2011) Induction of apoptosis by eugenol in human breast cancer cells. Indian J Exp Biol 49:871–878PubMedGoogle Scholar
  78. Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X, Zhang J, SX Q-S (2011) Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011:419343.
  79. Wiseman M (2008) The second world cancer research fund/American institute for cancer research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 67:253–256CrossRefPubMedGoogle Scholar
  80. Wu B, Zhang Q, Shen W, Zhu J (2008) Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Mol Cell Biochem 313:125–132CrossRefPubMedGoogle Scholar
  81. Yang L, Liu X, Lu Z, Chan JY, Zhou L, Fung KP, Wu P, Wu S (2010) Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis inducing factor. Cancer Lett 298:128–138CrossRefPubMedGoogle Scholar
  82. Yesil-Celiktas O, Sevimli C, Bedir E, Vardar-Sukan F (2010) Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65:158–163CrossRefPubMedGoogle Scholar
  83. Zhang YY, Deng T, Hu ZF, Zhang QP, Zhang J, Jiang H (2006) Mechanisms of inhibiting proliferation and inducing apoptosis of human gastric cancer cell line SGC7901 by ursolic acid. Chin J Cancer 25:432–437Google Scholar
  84. Zhao Y, Chang SK, Qu G, Li T, Cui H (2009) Beta-sitosterol inhibits cell growth and induces apoptosis in SGC-7901 human stomach cancer cells. J Agric Food Chem 57:5211–5218CrossRefPubMedGoogle Scholar
  85. Zheljazkov VD, Cantrell CL, Tekwani B, Khan SI (2008) Content, composition, and bioactivity of the essential oils of three basil genotypes as a function of harvesting. J Agric Food Chem 56:380–385CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Naveen Kaushal
    • 1
  • Suresh Rao
    • 2
  • Preety Ghanghas
    • 1
  • Soniya Abraham
    • 2
  • Thomas George
    • 2
  • Sueallen D’souza
    • 2
  • Jeffey M. Mathew
    • 2
  • Jessica Chavali
    • 2
  • Mallappa Kumara Swamy
    • 3
  • Manjeshwar Shrinath Baliga
    • 2
  1. 1.Department of BiophysicsPanjab UniversityChandigarhIndia
  2. 2.Mangalore Institute of OncologyMangaloreIndia
  3. 3.Department of Crop Science, Faculty of AgricultureUniversiti Putra MalaysiaSerdangMalaysia

Personalised recommendations